To,
The Members,
CHANDRA BHAGAT PHARMA LIMITED
Your Directors have pleasure in submitting their 20rh Annual Report of the
Company together with the Audited Statements of Accounts for the year ended 31st
March, 2023.
FINANCIAL PERFORMANCE:
The Financial performance of the Company during the year was as under:
PARTICULARS |
Year Ended 31.03.2023 (In Lacs) |
Year Ended 31.03.2022 (In Lacs) |
| Income from operations |
11,967.22 |
9,407.56 |
| Other Income |
29.31 |
162.02 |
| Total re venue |
11,996.53 |
9,569.58 |
| Total Expenses |
11,880.34 |
9,459.96 |
| Profit before tax |
116.19 |
109.62 |
| Current Tax |
29.33 |
27.08 |
| Deferred Tax Charge |
0. 16 |
0. 24 |
| Tax Expenses of Earlier years |
(3.85) |
2.63 |
| Profit after tax |
90.54 |
79.67 |
BUSINESS OPERATION:
The year under the review is having higher turnover and profit by way of financial
performance, as company by earlier year. Your directors are expecting robust growth in
near future.
The Gross income from operations of your Company is Rs. 11,967.22/- (in lacs) as
against Rs. 9,407.56/- (in lacs) in the previous year. The net profit after tax for the
year under review is Rs. 90.54 /- (in lacs) as against Rs. 79.67 /- (in lacs) in the
previous year.
DIVIDEND
The Board of Directors' do not recommend any dividend for the year under review as the
Directors wants to retain profit for the future expansion of the Company.
AMOUNT TRANSFERRED TO RESERVES
The Company has ploughed back its profits into the business and hence transferred
theCurrent Year's Profit to reserves & Surplus Account.
ANNUAL RETURN:
As per Section 92(3) R/w Rule 12 of Companies (Management & Administration) Rules,
extract of Annual Return of company in form MGT-9 is provided in the "Annexure A".
NUMBER OF BOARD MEETINGS/ GENERAL MEETING CONDUCTED DURING THE YEAR
During the year ended March 31st, 2023, the Board met 5 times. The
intervening gap between the Meetings was within the period prescribed under the Companies
Act, 2013 (the "Act"). Required quorum was present throughout each meeting as
per the requirement of the said Act, the details of Board meetings are given below;
Sr. No. |
Board Meeting Dates |
1. |
01.04.2022 |
2. |
26.05.2022 |
3. |
05.09.2022 |
4. |
14.11.2022 |
5. |
27.02.2023 |
Sr. No. General Meeting Date |
Purpose |
AGM / EGM |
| 1. 30/09/2022 |
1. Adoption of Accounts, Boards' Report and Auditor's Report for the F.Y.
ended March 31st, 2022. |
AGM |
|
2. Re-Appointment of Mr. Hemant Chandravadan Bhagat (DIN: 00233530) as a
Director liable to retire by rotation. |
|
|
3. Approval of Appointment of Statutory Auditor. |
|
AUDIT COMMITTEE
The audit committee of the Company is constituted under the provisions of Section 177
ofthe Companies Act, 2013.
Composition of the Committee during F.Y. 2022-23:
1. Ravindra Gajanan Awati, Non-Executive, Independent Director (Chairman);
2. Abha Praveen Doshi, Non-Executive, Independent Director (Member);
3. Hemant Chandravadan Bhagat, Managing Director (Member) and
4. Rajni Dawani (Secretary)
Audit Committee meetings during F.Y. 2022-23:
During the year under review, the Company held 5 Audit Committee meeting on 01/04/2022,
26/05/2022, 05/09/2022, 14/11/2022 and 27/02/2023.
NOMINATION AND REMUNERATION COMMITTEE:
The Nomination and Remuneration Committee of the Company is constituted under the
provisions of Sectionl78 of the Companies Act, 2013.
Composition of the Committee during F.Y. 2022-23:
1. Abha Praveen Doshi, Non-Executive, Independent Director (Chairman);
2. Ravindra Gajanan Awati, Non-Executive, Independent Director (Member);
3. Pranav Hemant Bhagat, Wholetime Director (Member) and
4. Rajni Dawani (Secretary)
Nomination and Remuneration Committee meetings during F.Y. 2022-23:
During the year under review, the Company held 3 Nomination and Remuneration Committee
meeting on 26/05/2022, 14/11/2022 and 27/02/2023.
STAKEHOLDERS RELATIONSHIP COMMITTEE:
The Stakeholders Relationship Committee of the Company is constituted under
theprovisions of Section 178 of the Companies Act, 2013.
Composition of the Committee during F.Y. 2022-23:
1. Ravindra Gajanan Awati, Non-Executive, Independent Director (Chairman);
2. Abha Praveen Doshi, Non-Executive, Independent Director (Member);
3. Hemant Chandravadan Bhagat, Managing Director (Member) and
4. Rajni Dawani (Secretary)
Stakeholders Relationship Committee meetings during F.Y. 2022-23:
During the year under review, the Company held 3 Stakeholders Relationship Committee
meeting on 26/05/2022, 14/11/2022 and 27/02/2023.
INTERNAL COMPLAINT COMMITTEE:
The Internal Complaint Committee of the Company is constituted pursuant to the
provision Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal)
Act, 2013 ("Act").
Composition of the Committee:
Name of the Director |
Designation in the Committee |
| Mr. Hemant Chandravadan Bhagat |
Presiding Officer |
| Mr. Pranav Hemant Bhagat |
Member |
| Mrs. Prachi Pranav Bhagat |
Member |
MEETING OF INDEPENDENT DIRECTOR:
The Meeting of the Independent Director held on 26th May, 2023.
DECLARATION OF THE INDEPENDENT DIRECTORS:
All Independent Directors have also given declarations that they meet the criteria of
independence as laid down under Section 149(6) of the Companies Act, 2013.
SHARE CAPITAL:
During the year under review, The Authorised Share Capital of the Company Remained at
Rs. 8,50,00,000.
During the year under review, The Paid up Share Capital of the Company also Remained at
Rs. 7,54,50,560.
DIRECTOR S'S RESPONSIBILITY STATEMENT:
In accordance with the provisions of Section 134(5) of the Companies Act, 2013 the
Boardof
Directors of the company confirms that-
a. In the preparation of the annual accounts for the year ended 31st March,
2023, the Company has followed the applicable accounting standards and there are no
material departures from the same.
b. Accounting policies were adopted and applied consistently and made judgments and
estimates that are reasonable and prudent so as to give a true and fair view of the
affairs of the Company as at 31st March, 2023 and of the Profit of the Company
for year ended on that date.
c. The Directors have taken proper and sufficient care for the maintenance of adequate
accounting records in accordance with the provisions of the Act of safeguarding the assets
of the Company and for preventing/ detecting fraud and irregularities have been taken.
d. The Directors have prepared Annual Accounts on a "Going Concern" basis.
e. They have laid down internal financial controls to be followed by the Company and
such internal financial controls are adequate and operating effectively;
f. The Directors had devised proper systems to ensure compliance with the provisions of
all applicable laws and that such systems were adequate and operating effectively.
PERFORMANCE EVALUATION:
The Board of Directors carried out an annual evaluation of the Board itself, its
Committees and individual Directors. The entire Board carried out performance evaluation
of each Independent Director excluding the Independent Director being evaluated. The
Nomination Remuneration Committee also carried out evaluation of every director's
performance.
The evaluation was done after taking into consideration inputs received from the
Directors, setting out parameters of evaluation. Evaluation parameters of the Board and
Committees were mainly based on Disclosure of Information, Key functions of the Board and
Committees, Responsibilities of the Board and Committees, etc. Evaluation parameters of
Individual Directors including the Chairman of the Board and Independent Directors were
based on Knowledge to Perform the Role, Time and Level of Participation, Performance of
Duties and Level of Oversight and Professional Conduct etc.
Independent Directors in their separate meeting evaluated the performance of
NonIndependent Directors, Chairman of the Board and the Board as a whole.
CORPORATE GOVERNANCE:
In terms of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
exempts companies which have listed their specified securities on SME Exchange from
compliance with corporate governance provisions.
Since the equity share capital of your Company is listed exclusively on the SME
Platform of BSE, the Company is exempted from compliance with Corporate Governance
requirements, and accordingly the reporting requirements like Corporate Governance Report,
Business Responsibility Report etc. are not applicable to the Company.
MANAGEMENT DISCUSSION AND ANALYSIS REPORT:
The Management Discussion and Analysis report has been separately furnished as"Annexure-
B" in the Annual Report and forms a part of the Annual Report.
POLICIES AND DISCLOSURE REQUIREMENTS:
In terms of provisions of the Companies Act, 2013, the Company has adopted following
policies which are available on its website http://cbcpharma.com/
• Vigil Mechanism Policy
• Code for Independent Directors
• Nomination and Remuneration Policy (Attached below)
• Risk Management Policy
• Code of Conduct Director and Sr. Management
• Code of Conduct for prevention of Insider Trading
• Policy on Related Party Transactions
COMPANY'S POEICY RELATING TO APPOINTMENT. PAYMENT OF REMUNERATION TODTRECTORS AND
DISCHARGE OF THEIR DUTIES
Pursuant to the provision of Section 178 of the Companies Act, 2013 and at the
recommendation of Nomination and Remuneration Committee has devised Nomination and
Remuneration Policy relating to appointment of Key Managerial Personnel and Directors,
Directors qualifications, positive attributes, independence of Directors and their
remuneration and other related matters as provided under Section 178(3) of the Companies
Act, 2013. The brief abstract of the Policy is given below:
Policy Abstract:
I. The role of the Committee as per the Nomination & Remuneration Policy will be as
under:
• To formulate criteria for determining qualifications, positive attributes and
independence of a Director.
• To formulate criteria for evaluation of Independent Directors and the Board.
• To identify persons who are qualified to become Directors and who may be
appointed in Senior Management in accordance with the criteria laid down in this policy.
• To carry out evaluation of Director's performance.
• To recommend to the Board the appointment and removal of Directors and Senior
Management.
• To recommend to the Board policy relating to remuneration for Directors, Key
Managerial Personnel and Senior Management.
• To devise a policy on Board diversity, composition, size.
• Succession planning for replacing Key Executives and overseeing.
• To carry out any other function as is mandated by the Board from time to time
and / or enforced by any. Statutory notification, amendment or modification, as may be
applicable.
• To perform such other functions as may be necessary or appropriate for the
performance ofits duties.
II Policy for Appointment and Removal of Director, Key Managerial Personnel and Senior
Management:
a) The Committee shall identify and ascertain the integrity, qualification, expertise
and experience of the person for appointment as Director, KMP or at Senior Management
level and recommend his / her appointment, as per Company's Policy.
b) A person should possess adequate qualification, expertise and experience for the
position he / she is considered for appointment. The Committee has authority to decide
whether qualification, expertise and experience possessed by a person is sufficient /
satisfactory for the position.
c) The Company shall not appoint or continue the employment of any person as Whole-time
Director who has attained the age of seventy years. Provided that the term of the person
holding this position may be extended beyond the age of seventy years with the approval of
shareholders by passing a special resolution.
in. Policy for Remuneration to Directors / KMP/ Senior Management Personnel:
1) Remuneration to Managing Director /Whole-time Directors:
a) The Remuneration/Commission etc. to be paid to Managing Director / Wholetime
Directors, etc. shall be governed as per provisions of the Companies Act, 2013 and rules
made there under or any other enactment for the time being enforce and the approval so
obtained from the Members of the Company.
b) The Nomination and Remuneration Committee shall make such recommendations to the
Board of Directors as it may consider appropriate with regard to remuneration to Managing
Director /Whole-time Directors.
2) Remuneration to Non-Executive/ Independent Directors:
a) The Non-Executive /Independent Directors may receive sitting fees and such other
remuneration as permissible under the provisions of Companies Act, 2013. The amount of
sitting fees shall be such as may be recommended by the Nomination and Remuneration
Committee and approved by the Board of Directors.
b) All the remuneration of the Non-Executive / Independent Directors (excluding
remuneration for attending meetings as prescribed under Section 197 (5) of the Companies
Act, 2013) shall be subject to ceiling/ limits as provided under Companies Act, 2013 and
rules made there under or any other enactment for the time being in force. The amount of
such remuneration shall be such as may be recommended by the Nomination and Remuneration
Committee and approved by the Board of Directors or shareholders as the case may be.
c) An Independent Director shall not be eligible to get Stock Options and also shall
not be eligible to participate in any share based payment schemes of the Company.
d) Any remuneration paid to Non-Executive /Independent Directors for services rendered
which are of professional in nature shall not be considered as part of the remuneration
for the purposes of clause (b) above if the following conditions are satisfied:
i) The Services are rendered by such Director in his capacity as the professional ;and
ii) In the opinion of the Committee, the director possesses the requisite qualification
forthe practice of that profession.
3) Remuneration to Kev Managerial Personnel and Senior Management:
a) The remuneration to Key Managerial Personnel and senior Management shall consist of
fixed pay and incentive pay, in compliance with the provisions of the Companies Act, 2013
and in accordance with the Company's Policy.
b) The Fixed pay shall include monthly remuneration, employer's contribution to
Provident Fund, contribution to pension fund, pension schemes, etc. as decided from time
to time.
c) The Incentive pay shall be decided based on the balance between performance of the
Company and performance of the Key Managerial Personnel and Senior Management, to be
decided annually or at such intervals as may be
Considered appropriate.
PARTICULARS OF LOANS. GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF THE COMPANIES
ACT. 2013:
The particulars pertaining to Section 186 of Companies Act, 2013 relating to loans,
Guarantees and Investments are not applicable to the company. The disclosure of other
loans, guarantees and investments are made in financial statements of the company.
PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WTTHRELATED PARTIES:
All related party transactions that were entered during the financial year were on
arm's length basis and were in the ordinary course of business. There are no significant
related party transactions made by the Company with Promoters, Directors, Key Managerial
Personnel or other designated persons which may have a potential conflict with the
interest of the Company at large.
Accordingly, particulars of contracts or arrangements with related party referred to in
Section 188(1) along with the justification for entering into such contract or arrangement
in Form AOC-2 does not form part of the report.
COMPLIANCE WTTH SECRETARIAT. STANDARDS:
The Company has complied with Secretarial Standards issued by the Institute of Company
Secretaries of India on Board Meetings and Annual General Meetings.
MATERIAL CHANCES AND COMMITMENT:
No material changes and commitments affecting the financial position of the Company
occurred between the end of the financial year to which this financial statements relate
on the date of this report.
CONSERVATION OF ENERGY. TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:
(A) CONSERVATION OF ENERGY:
The Company has been continuously making efforts to reduce energy consumption. The
management is striving to achieve cost reduction by economical usage of energy.
(i) The steps taken or impact on conservation of energy:
The Company has been continuously making efforts to reduce energy consumption and the
management is striving to achieve cost reduction by economical usage of energy.
(ii) The steps taken by the company for utilizing alternate source of energy:
As the Company needs only minimum level of energy, it has not looked in to an
alternative source of energy.
(iii) The capital investment on energy conservation equipment:
The Company has not made any capital investment as it is not required at this stage.
(B) TECHNOLOGY ABSORPTION:
The company does not use any imported technology and the company is not into field of
research and development and hence no major cost incurred during the period under review.
(C) FOREIGN EXCHANGE EARNINGS AND OUT GO:
There was given below Foreign Exchange earnings and outgo during the financial year as
required by the Companies (Accounts) Rules, 2014.
Details of earnings in foreign exchange:
Particulars |
Current Year (In Lacs) 01.04.22 -
31.03.23 |
Previous Year (In Lacs) 01.04.21 -
31.03.22 |
| Export of Goods calculated on FOB Basis |
5758.09 |
7,111.15 |
| Interest and dividend |
- |
- |
| Royalty |
- |
- |
| Know-how |
- |
- |
| Professional and Consultancy fees |
- |
- |
| Other Income |
- |
- |
Total earning in foreign exchange |
5758.09 |
7,111.15 |
Details of expenditure in foreign exchange:
Particulars |
Current Year (in lacs) 01.04.22 -
31.03.23 |
Previous Year (in lacs) 01.04.21 -
31.03.22 |
| Import of Capital Goods calculated on CIF Basis: |
69.69 |
107.52 |
| (i) raw material |
- |
- |
| (ii) component and spare parts |
- |
- |
| (iii) capital goods - Software Purchase |
- |
- |
| Expenditure on |
- |
- |
| account of: |
|
|
| Royalty |
- |
- |
| Know-how |
- |
- |
| Professional and Consultancy fees |
- |
- |
| Interest |
- |
- |
| Other matters |
- |
- |
| Dividend paid |
- |
- |
Total expenditure in foreign exchange |
69.69 |
107.52 |
STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF RISK MANAGEMENT POETCY OF THE
COMPANY:
Risk Management is the process of identification, assessment and prioritization of
risks followed by coordinated efforts to minimize, monitor and mitigate/control the
probability and/or impact of unfortunate events or to maximize the realization of
opportunities. The Company has laid down a comprehensive Risk Assessment and Minimization
Procedure which is reviewed by the Board from time to time. These procedures are reviewed
to ensure that executive management controls risk through means of a properly defined
framework. The major risks have been identified by the Company and its mitigation
process/measures have been formulated in the areas such as business, project execution,
event, financial, human, environment and statutory compliance.
DETAILS OF POLICY DEVELOPED AND IMPLEMENTED BY THE COMPANY ON ITS CORPORATE SOCIAL
RESPONSIBILITY INITIATIVES:
The provisions of Section 135 of the Companies Act, 2013 read with Companies (Corporate
Social Responsibility Policy) Rules, 2014 are not applicable to the Company as on March
31, 2023. Hence, your Company is not required to adopt the CSR Policy or constitute CSR
Committee during the year under review.
DEPOSITS:
The company has not accepted / renewed any deposits during the year under review. DIRECTORS:
The Board is duly constituted according to the provisions of the Company Act.
The Directors on the Board have submitted notice of interest under Section 184(1),
intimation under Section 164(2) of the Companies Act, 2013 and declaration as to
compliance with the Code of Conduct of the Company.
The present Directors of the Company are Mr. Pranav Hemant Bhagat, Mr. Hemant
Chandravadan Bhagat, Mr. Ravindra Gajanan Awati, Ms. Prachi Pranav Bhagat and Ms Abha
Praveeen Doshi.
| s. No. Name of Director/ KMP |
Designation |
Promoter/ Independent |
Executive/ Non Executive |
Date of Appointment |
| 1. Hemant Chandravadan Bhagat |
Managing Director |
Promoter |
Chairman |
10/03/2003 |
| 2. Pranav Hemant Bhagat |
Whole time Director |
Promoter |
Executive |
17/05/2004 |
3. Prachi Pranav Bhagat |
Director |
Promoter |
Executive |
25/09/2018 |
| 4. Prachi Pranav Bhagat |
CFO |
KMP |
Executive |
31/08/2019 |
5. Ravindra Gajanan Awati |
Director |
Independent |
Non - Executive |
31/08/2019 |
| 6. Abha Praveen Doshi |
Director |
Independent |
Non - Executive |
15/07/2019 |
7. Rajni Dawani |
CS |
KMP |
Executive |
30/03/2022 |
In accordance with the provisions of the Companies Act, 2013, and the Articles of
Association of the Company, Mr. Pranav Hemant Bhagat retires by rotation at the
forthcoming Annual General Meeting and being eligible, offers himself for re-appointment.
STATUTORY AUDITORS:
As per the provisions of Section 139 of the Act read with the Companies (Audit and
Auditors) Rules, 2014, the members of the Company proposed to appoint M/s. A Y &
COMPANY, Chartered Accountants (Firm Registration No. 020829C) as the Statutory
Auditor of your Company in forthcoming AGM scheduled on 30.09.2023 for a period of 5 years
to hold office till the conclusion of Annual General Meeting to be held in the year 2028.
The Company has received written confirmation to the effect that they are not
disqualified from acting as the Statutory Auditors of the Company in the terms of
provisions of Section 139 and 141 of the Act and rules framed there under.
INTERNAL FINANCIAL CONTROL SYSTEMS AND THEIR ADEQUACY:
The Board has laid down standards, processes and procedures for implementing the
internal financial controls across the organization. After considering the framework of
existing internal financial controls and compliance systems; work performed by the
Statutory Auditors, Secretarial Auditors and External Consultants; reviews performed by
the Management and relevant Board Committees including the Audit Committee, the Board is
of the opinion that the Company's internal financial controls with reference to the
financial statements were adequate and effective during the F.Y. 2022-23.
INTERNAL CONTROL SYSTEMS:
Adequate internal control systems commensurate with the nature of the Company's
business and size and complexity of its operations are in place and have been operating
satisfactorily. Internal control systems comprising of policies and procedures are
designed to ensure reliability of financial reporting, timely feedback on achievement of
operational and strategic goals, compliance with policies, procedure, applicable laws and
regulations
and that all assets and resources are acquired economically, used efficiently and
adequately protected.
SECRETARIAL AUDIT:
In accordance with the provisions of Section 204 of the Companies Act, 2013 read with
the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the
Board has appointed M/s. Amit Dharmani & Associates, Company Secretaries, as
Secretarial Auditors for the F.Y. 2022-23. The Secretarial Audit Report for the financial
year ended March 31, 2023 is set out in "Annexure-C" to this
Report.
COST AUDITOR:
As per provision of section 148(3) of Companies Act, 2013 and Rule 6(2) of Companies
(Cost records and audit) Rules, 2014, the Company is not required to appoint a cost
auditor to audit the cost records of the Company.
PARTICULARS OF EMPLOYEES AND REMUNERATION
The information required under Section 197 & Rule 5 of the Companies (Appointment
and Remuneration of Managerial Personnel) Rules, 2014 is given below.
a) Ratio of remuneration of each Director to the employees' median remuneration:
Director |
Designation |
Remuneration P.A. (in lacs.) |
Ratio |
| Hemant Chandravadan Bhagat |
Managing Director |
12.00 |
10.19 |
| Pranav Hemant Bhagat |
Wholetime Director |
12.00 |
10.19 |
b) Percentage increase in the median remuneration of employees in the Financial Year
2022-23: NIL
c) Number of permanent employees on the rolls of the Company as on March 31st,
2023 :-29
d) Average percentile increase made in the salaries of employees other than key
managerial personnel in the last financial year and its comparison with the percentile
increase in the managerial remuneration and justification thereof and point out if there
are any exceptional circumstances for increase in the managerial remuneration:
e) It is hereby affirmed that the remuneration paid during the year is as per the
Remuneration policy of the Company.
f) There is no employee covered under the provisions of Section 197(14) of the
Companies Act, 2013.
There was no employee in the Company who drew remuneration of Rs. 1,02,00,000/- per
annum during the period under review. Hence, the Company is not required to disclose any
information as per Rule 5(2) of the Companies (Appointment and Remuneration) Rules, 2014.
EXPLANATION ON AUDITORS REPORTS
A. Auditors Report
There are no qualifications or reservation or adverse remarks made by the Auditors in
their report for the year under review.
B. Annual Report
There are no qualifications or reservation or adverse remarks made by the Auditors in
their report for the year under review.
REPORTING OE FRAUDS BY AUDITORS
During the year under review, the Statutory Auditors have not reported any instances of
frauds committed in the Company by its Officers or Employees under Section 143(12) of the
Companies Act, 2013.
GENERAL:
Your Directors state that no disclosure or reporting is required in respect of the
following items as there were no transaction on these items during the year under review.
1. Details relating to Deposits covered under Chapter V of the Act.
2. Issue of equity shares with differential rights as to dividend, voting or otherwise.
3. Issue of equity shares (including sweat equity shares) and ESOS to employees of the
Company under any scheme.
4. No significant or material orders were passed by the Regulators or Courts or
Tribunals which impact the going concern status and Company's operations in
future.
5. There were no instance of non-exercising of voting rights in respect of shares
purchased directly by the employees under a scheme pursuant to Section 67(3) of the Act
read with Rule 16(4) of Companies (Share Capital and Debenture) Rules, 2014 and hence no
information has been furnished.
ACKNOWLEDGEMENTS:
Your Directors would like to express their sincere appreciation of the co-operation and
assistance received from Shareholders, Bankers, regulatory bodies and other business
constituents during the year under review.
Your Directors also wish to place on record their deep sense of appreciation for the
commitment displayed by all executives, officers and staff, resulting in successful
performance of the Company during the year. Your Directors look forward to the
continued support of all stakeholders in the future.
For and on behalf of
CHANDRA BHAGAT PHARMA LIMITED |
|
HEMANT C BHAGAT MANAGING DIRECTOR (DIN: 00233530) |
PRANAV HEMANT BHAGAT WHOLETIME DIRECTOR (DIN: 00156362) |
PLACE: MUMBAI DATE: 05.09.2023 |
|
|